| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $5.2B | $4.4B | $3.5B |
| Cost of Revenue | $0.9B | $0.8B | $0.6B |
| Gross Profit | $4.3B | $3.6B | $2.9B |
| R&D Expense | $2.7B | $2.2B | $1.9B |
| SG&A Expense | — | — | — |
| Operating Income | $-0.1B | $-0.1B | $-0.3B |
| Net Income | $-0.3B | $-0.3B | $-0.5B |
| EPS (Basic) | $-0.98 | $-1.16 | $-1.90 |
| EPS (Diluted) | $-0.98 | $-1.16 | $-1.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $6.0B | $5.2B | $4.1B |
| Current Assets | $3.9B | $3.1B | $2.7B |
| Cash & Equivalents | $2.5B | $2.2B | $2.1B |
| Total Liabilities | $4.7B | $4.2B | $3.5B |
| Current Liabilities | $3.2B | $2.6B | $2.0B |
| Stockholders' Equity | $1.3B | $1.0B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.4B | $0.9B |
| Investing Cash Flow | $-0.3B | $-1.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.8B | $-0.4B | $-0.1B |